JP2017518965A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017518965A5 JP2017518965A5 JP2016564612A JP2016564612A JP2017518965A5 JP 2017518965 A5 JP2017518965 A5 JP 2017518965A5 JP 2016564612 A JP2016564612 A JP 2016564612A JP 2016564612 A JP2016564612 A JP 2016564612A JP 2017518965 A5 JP2017518965 A5 JP 2017518965A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- domain monomer
- polypeptide
- monomer
- igg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020084900A JP7593745B2 (ja) | 2014-05-02 | 2020-05-14 | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461987863P | 2014-05-02 | 2014-05-02 | |
| US61/987,863 | 2014-05-02 | ||
| US201462081923P | 2014-11-19 | 2014-11-19 | |
| US62/081,923 | 2014-11-19 | ||
| PCT/US2015/028926 WO2015168643A2 (en) | 2014-05-02 | 2015-05-01 | Compositions and methods related to engineered fc constructs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020084900A Division JP7593745B2 (ja) | 2014-05-02 | 2020-05-14 | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017518965A JP2017518965A (ja) | 2017-07-13 |
| JP2017518965A5 true JP2017518965A5 (enExample) | 2018-06-07 |
Family
ID=54359511
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016564612A Pending JP2017518965A (ja) | 2014-05-02 | 2015-05-01 | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
| JP2020084900A Active JP7593745B2 (ja) | 2014-05-02 | 2020-05-14 | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
| JP2022066669A Active JP7600172B2 (ja) | 2014-05-02 | 2022-04-14 | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020084900A Active JP7593745B2 (ja) | 2014-05-02 | 2020-05-14 | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
| JP2022066669A Active JP7600172B2 (ja) | 2014-05-02 | 2022-04-14 | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10239944B2 (enExample) |
| EP (2) | EP4299595A3 (enExample) |
| JP (3) | JP2017518965A (enExample) |
| KR (1) | KR102546875B1 (enExample) |
| CN (2) | CN113501880A (enExample) |
| AU (2) | AU2015252866B2 (enExample) |
| CA (1) | CA2941072A1 (enExample) |
| DK (1) | DK3137506T5 (enExample) |
| ES (1) | ES2962694T3 (enExample) |
| IL (3) | IL286367B2 (enExample) |
| PL (1) | PL3137506T3 (enExample) |
| SG (2) | SG10201913507SA (enExample) |
| WO (1) | WO2015168643A2 (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2016139006A (ru) | 2014-03-05 | 2018-04-05 | Юсб Биофарма Спрл | Мультимерные fc-белки |
| SG10201913507SA (en) | 2014-05-02 | 2020-02-27 | Momenta Pharmaceuticals Inc | Compositions and methods related to engineered fc constructs |
| MX383614B (es) | 2015-05-21 | 2025-03-14 | Harpoon Therapeutics Inc | Proteinas de union triespecificas y metodos de uso. |
| SI3325011T1 (sl) | 2015-07-24 | 2021-02-26 | Gliknik Inc. | Fuzijski proteini humanih proteinskih fragmentov za tvorbo pravilnih multimeriziranih imunoglobulin FC sestavkov s povečanim vezanjem komplementa |
| EP3356561B1 (en) | 2015-10-02 | 2021-10-27 | Momenta Pharmaceuticals, Inc. | Therapeutic and diagnostic methods for autoimmune diseases and/or inflammation |
| WO2017151971A2 (en) | 2016-03-02 | 2017-09-08 | Momenta Pharmaceuticals, Inc. | METHODS RELATED TO ENGINEERED Fc CONSTRUCTS |
| US11623958B2 (en) | 2016-05-20 | 2023-04-11 | Harpoon Therapeutics, Inc. | Single chain variable fragment CD3 binding proteins |
| US10100106B2 (en) | 2016-05-20 | 2018-10-16 | Harpoon Therapeutics, Inc. | Single domain serum albumin binding protein |
| CA3025310A1 (en) | 2016-05-23 | 2017-11-30 | Momenta Pharmaceuticals, Inc. | Compositions and methods related to engineered fc constructs |
| CA3026420A1 (en) | 2016-06-07 | 2017-12-14 | Gliknik Inc. | Cysteine-optimized stradomers |
| CA3203613A1 (en) * | 2016-07-19 | 2018-01-25 | Ibentrus, Inc. | Bispecific proteins and methods for preparing same |
| SG11201900427PA (en) | 2016-07-22 | 2019-02-27 | Gliknik Inc | Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced fc receptor binding |
| EP3551647A4 (en) | 2016-12-09 | 2021-01-13 | Gliknik Inc. | MANUFACTURING OPTIMIZATION OF GL-2045, A MULTIMERIZING STRADOMER |
| IL266988B2 (en) | 2016-12-09 | 2024-11-01 | Gliknik Inc | Methods of treating inflammatory disorders with multivalent fc compounds |
| KR102624254B1 (ko) | 2017-01-06 | 2024-01-12 | 모멘타 파머슈티컬스 인코포레이티드 | 유전자 조작 Fc 작제물에 관한 조성물 및 방법 |
| AU2018205272A1 (en) * | 2017-01-06 | 2019-07-25 | Momenta Pharmaceuticals, Inc. | Compositions and methods related to engineered Fc-antigen binding domain constructs |
| WO2018160754A2 (en) * | 2017-02-28 | 2018-09-07 | Harpoon Therapeutics, Inc. | Inducible monovalent antigen binding protein |
| AU2018265856B2 (en) | 2017-05-12 | 2023-04-27 | Harpoon Therapeutics, Inc. | Mesothelin binding proteins |
| CN110709415A (zh) | 2017-06-02 | 2020-01-17 | 辉瑞大药厂 | 重组robo2蛋白、组合物、方法及其用途 |
| JP6951545B2 (ja) * | 2017-07-21 | 2021-10-20 | トリアンニ インコーポレイテッドＴｒｉａｎｎｉ，Ｉｎｃ． | 単鎖ｖｈ及び重鎖抗体 |
| US11077199B2 (en) | 2017-08-09 | 2021-08-03 | Massachusetts Institute Of Technology | Albumin binding peptide conjugates and methods thereof |
| IL315737A (en) | 2017-10-13 | 2024-11-01 | Harpoon Therapeutics Inc | B-cell maturation antigen-binding proteins |
| SI3694529T1 (sl) | 2017-10-13 | 2024-10-30 | Harpoon Therapeutics, Inc. | Trispecifične beljakovine in načini uporabe |
| AU2017439776B2 (en) * | 2017-11-20 | 2025-03-27 | Taizhou Mabtech Pharmaceutical Co., Ltd | Bifunctional fusion protein targeting CD47 and PD-l1 |
| MX2021000305A (es) * | 2018-07-11 | 2021-09-08 | Momenta Pharmaceuticals Inc | Composiciones y métodos relacionados con constructos de dominio de unión a antígeno-fc modificados genéticamente. |
| US20220267460A1 (en) * | 2018-07-11 | 2022-08-25 | Momenta Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS |
| JP2021530989A (ja) * | 2018-07-11 | 2021-11-18 | モメンタ ファーマシューティカルズ インコーポレイテッド | ＰＤ−Ｌ１を標的とした改変されたＦｃ抗原結合ドメイン構築体に関する組成物および方法 |
| AU2019301684A1 (en) * | 2018-07-11 | 2021-02-18 | Momenta Pharmaceuticals, Inc. | Compositions and methods related to engineered Fc-antigen binding domain constructs |
| US12195544B2 (en) | 2018-09-21 | 2025-01-14 | Harpoon Therapeutics, Inc. | EGFR binding proteins and methods of use |
| EP3856771A4 (en) | 2018-09-25 | 2022-06-29 | Harpoon Therapeutics, Inc. | Dll3 binding proteins and methods of use |
| BR112021025426A2 (pt) * | 2019-06-19 | 2022-06-21 | Bioverativ Therapeutics Inc | Fator recombinante viii-fc para tratamento de hemofilia e baixa densidade mineral óssea |
| BR112022003713A2 (pt) | 2019-09-13 | 2022-08-09 | CSL Behring Lengnau AG | Multímeros de fc de igg recombinantes para o tratamento de doenças renais mediadas por imunocomplexo |
| EP4069292A1 (en) | 2019-12-06 | 2022-10-12 | CSL Behring Lengnau AG | Stable compositions of fc multimers |
| JP2023507033A (ja) * | 2019-12-20 | 2023-02-20 | キソジ・バイオテクノロジー・インコーポレイテッド | ポリペプチド、タンパク質複合体及びそれを作製する方法 |
| JP2023535677A (ja) | 2020-07-10 | 2023-08-21 | バイオモレキュラー・ホールディングス・エルエルシー | 四面体抗体 |
| US20250084169A1 (en) | 2022-01-12 | 2025-03-13 | Biomolecular Holdings Llc | Nk/monocyte engagers |
| KR20250042176A (ko) | 2022-07-27 | 2025-03-26 | 아블린쓰 | 신생아 fc 수용체의 특정 에피토프에 결합하는 폴리펩타이드 |
| JP2025536568A (ja) * | 2022-11-02 | 2025-11-07 | 北京昌平實驗室 | 融合タンパク質及びその応用 |
| CN120813375A (zh) | 2023-01-30 | 2025-10-17 | 凯玛布有限公司 | 抗体 |
| AR131869A1 (es) | 2023-02-17 | 2025-05-07 | Ablynx Nv | POLIPÉPTIDOS QUE SE UNEN AL RECEPTOR DE Fc NEONATAL |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2556219B1 (fr) | 1983-12-07 | 1987-06-26 | Merieux Inst | Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines |
| US5426641A (en) | 1994-01-28 | 1995-06-20 | Bell Communications Research, Inc. | Adaptive class AB amplifier for TDMA wireless communications systems |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| CA2257861A1 (en) | 1996-06-14 | 1997-12-18 | Smithkline Beecham Corporation | Hexameric fusion proteins and uses therefor |
| US20090074839A1 (en) | 1997-01-22 | 2009-03-19 | Marton Milankovits | Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications |
| US7951917B1 (en) | 1997-05-02 | 2011-05-31 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| US20020062010A1 (en) * | 1997-05-02 | 2002-05-23 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US7608681B2 (en) * | 1999-12-24 | 2009-10-27 | Genentech, Inc. | Methods and compositions for prolonging elimination half-times of bioactive compounds |
| US20050089932A1 (en) | 2001-04-26 | 2005-04-28 | Avidia Research Institute | Novel proteins with targeted binding |
| WO2005077981A2 (en) | 2003-12-22 | 2005-08-25 | Xencor, Inc. | Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES |
| US20060074225A1 (en) * | 2004-09-14 | 2006-04-06 | Xencor, Inc. | Monomeric immunoglobulin Fc domains |
| CN101198698B (zh) | 2005-03-31 | 2014-03-19 | 中外制药株式会社 | 通过调节多肽缔合制备多肽的方法 |
| US8354109B2 (en) * | 2005-12-13 | 2013-01-15 | Suppremol Gmbh | Multimeric Fc receptor polypeptides |
| GB0614780D0 (en) | 2006-07-25 | 2006-09-06 | Ucb Sa | Biological products |
| AR063384A1 (es) | 2006-10-25 | 2009-01-28 | Amgen Inc | Agentes terapeuticos a base de peptidos derivados de toxinas |
| BRPI0620639A2 (pt) | 2006-12-21 | 2011-11-22 | Micromet Ag | anticorpos de cadeia simples biespecìficos e composição farmacêutica compreendendo os mesmos |
| CA2682605A1 (en) | 2007-04-18 | 2008-10-30 | Zymogenetics, Inc. | Single chain fc, methods of making and methods of treatment |
| EP2158318A2 (en) | 2007-05-14 | 2010-03-03 | Biogen Idec MA, Inc. | Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto |
| CN103897063B (zh) * | 2007-06-01 | 2017-04-12 | 马里兰大学巴尔的摩分校 | 免疫球蛋白恒定区Fc受体结合剂 |
| WO2010135521A2 (en) | 2009-05-20 | 2010-11-25 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of influenza |
| EP3663318A1 (en) * | 2008-01-07 | 2020-06-10 | Amgen Inc. | Method for making antibody fc-heterodimeric molecules using electrostatic steering effects |
| HUE029925T2 (en) | 2008-04-02 | 2017-04-28 | Macrogenics Inc | HER2 / neu-specific antibodies and methods using them |
| WO2010042481A1 (en) | 2008-10-06 | 2010-04-15 | University Of Chicago | Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
| WO2010065578A2 (en) | 2008-12-04 | 2010-06-10 | Leukosight Inc. | POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME |
| WO2010080124A2 (en) | 2008-12-18 | 2010-07-15 | Dana-Farber Cancer Institute, Inc. | Nkg2d-fc for immunotherapy |
| BRPI1006998A2 (pt) | 2009-01-23 | 2015-08-25 | Biogen Idec Inc | Polipeptídeos fc estabilizados com função efetora reduzida e métodos de uso |
| WO2010135534A2 (en) | 2009-05-20 | 2010-11-25 | Children's Medical Center Corporation | Compositions for the treatment of metastatic cancer and methods of use thereof |
| CN102549016B (zh) | 2009-06-30 | 2015-05-06 | 研究发展基金会 | 免疫球蛋白fc多肽 |
| MX2012003396A (es) | 2009-09-16 | 2012-04-10 | Genentech Inc | Complejos de proteina conteniendo helice super-enrollada y/o enlazador tether y usos de los mismos. |
| AU2010303415B2 (en) | 2009-10-07 | 2015-02-19 | Macrogenics, Inc. | Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use |
| MX340971B (es) | 2009-11-23 | 2016-08-02 | Amgen Inc * | Fragmento cristalizable (fc) de anticuerpo monomerico. |
| GB0922209D0 (en) | 2009-12-18 | 2010-02-03 | Univ Nottingham | Proteins, nucleic acid molecules and compositions |
| ES2674567T3 (es) | 2010-05-21 | 2018-07-02 | Merrimack Pharmaceuticals, Inc. | Proteínas de fusión biespecíficas |
| HRP20191305T1 (hr) | 2010-07-09 | 2019-10-18 | Bioverativ Therapeutics Inc. | Preradive jednolančane molekule i polipeptidi izrađeni koristeći iste |
| EP3543257A1 (en) * | 2010-07-28 | 2019-09-25 | Gliknik Inc. | Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions |
| EP2603526A1 (en) | 2010-08-13 | 2013-06-19 | Medimmune Limited | Monomeric polypeptides comprising variant fc regions and methods of use |
| PL2635607T3 (pl) | 2010-11-05 | 2020-05-18 | Zymeworks Inc. | Projekt stabilnego przeciwciała heterodimerowego z mutacjami w domenie FC |
| CA2822366A1 (en) | 2010-12-23 | 2012-06-28 | Janssen Biotech, Inc. | Active protease-resistant antibody fc mutants |
| CA2827188C (en) | 2011-03-17 | 2020-02-11 | Ramot At Tel-Aviv University Ltd. | Bi- and monospecific, asymmetric antibodies and methods of generating the same |
| AU2012235758B2 (en) | 2011-03-25 | 2015-05-07 | IGI Therapeutics SA | Hetero-dimeric immunoglobulins |
| US20140370012A1 (en) * | 2012-01-27 | 2014-12-18 | Gliknik Inc. | Fusion proteins comprising igg2 hinge domains |
| AU2013270682A1 (en) | 2012-06-08 | 2014-12-11 | Biogen Ma Inc. | Procoagulant compounds |
| HK1209034A1 (en) | 2012-06-21 | 2016-03-24 | Indiana University Research And Technology Corporation | Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function |
| KR20150058236A (ko) * | 2012-08-20 | 2015-05-28 | 글리크닉 인코포레이티드 | 항원 결합 및 다가 fc 감마 수용체 결합 활성을 가진 분자 |
| AU2012392760C1 (en) * | 2012-10-17 | 2021-08-12 | CSL Behring Lengnau AG | Immunomodulatory proteins |
| CN104558194B (zh) | 2013-10-17 | 2018-04-27 | 泰州迈博太科药业有限公司 | 一类抗CD20-Flex双功能融合蛋白、其制备方法及用途 |
| JP2016538283A (ja) | 2013-11-13 | 2016-12-08 | ザイムワークス，インコーポレイテッド | Ｅｇｆｒ及び／またはｈｅｒ２を標的にする一価抗原結合性構築物及びその使用 |
| US10137170B2 (en) | 2013-12-20 | 2018-11-27 | Indiana University Research And Technology Corporation | Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptides |
| BR112016016411A2 (pt) | 2014-01-15 | 2017-10-03 | Hoffmann La Roche | VARIANTES DE REGIÕES-"Fc" COM PROPRIEDADES DE LIGAÇÃO DE "FcRn" MODIFICADAS |
| EP3835318B1 (en) | 2014-01-15 | 2025-10-29 | F. Hoffmann-La Roche AG | Fc-region variants with modified fcrn- and maintained protein a-binding properties |
| RU2016139006A (ru) | 2014-03-05 | 2018-04-05 | Юсб Биофарма Спрл | Мультимерные fc-белки |
| EP3114137A1 (en) | 2014-03-05 | 2017-01-11 | UCB Biopharma SPRL | Multimeric fc proteins |
| EP3131926A1 (en) | 2014-04-16 | 2017-02-22 | UCB Biopharma SPRL | Multimeric fc proteins |
| SG10201913507SA (en) | 2014-05-02 | 2020-02-27 | Momenta Pharmaceuticals Inc | Compositions and methods related to engineered fc constructs |
| SG10201913680PA (en) | 2014-05-29 | 2020-03-30 | Macrogenics Inc | Tri-specific binding molecules that specifically bind to multiple cancer antigens and methods of use thereof |
| WO2017151971A2 (en) | 2016-03-02 | 2017-09-08 | Momenta Pharmaceuticals, Inc. | METHODS RELATED TO ENGINEERED Fc CONSTRUCTS |
| CA3025310A1 (en) | 2016-05-23 | 2017-11-30 | Momenta Pharmaceuticals, Inc. | Compositions and methods related to engineered fc constructs |
| KR102624254B1 (ko) | 2017-01-06 | 2024-01-12 | 모멘타 파머슈티컬스 인코포레이티드 | 유전자 조작 Fc 작제물에 관한 조성물 및 방법 |
-
2015
- 2015-05-01 SG SG10201913507SA patent/SG10201913507SA/en unknown
- 2015-05-01 SG SG11201607070VA patent/SG11201607070VA/en unknown
- 2015-05-01 KR KR1020167029772A patent/KR102546875B1/ko active Active
- 2015-05-01 WO PCT/US2015/028926 patent/WO2015168643A2/en not_active Ceased
- 2015-05-01 ES ES15785583T patent/ES2962694T3/es active Active
- 2015-05-01 AU AU2015252866A patent/AU2015252866B2/en active Active
- 2015-05-01 CA CA2941072A patent/CA2941072A1/en active Pending
- 2015-05-01 JP JP2016564612A patent/JP2017518965A/ja active Pending
- 2015-05-01 CN CN202110761899.9A patent/CN113501880A/zh active Pending
- 2015-05-01 EP EP23193565.1A patent/EP4299595A3/en active Pending
- 2015-05-01 PL PL15785583.4T patent/PL3137506T3/pl unknown
- 2015-05-01 CN CN201580020385.0A patent/CN106661125B/zh active Active
- 2015-05-01 DK DK15785583.4T patent/DK3137506T5/da active
- 2015-05-01 EP EP15785583.4A patent/EP3137506B1/en active Active
- 2015-05-01 IL IL286367A patent/IL286367B2/en unknown
-
2016
- 2016-04-28 US US15/141,413 patent/US10239944B2/en active Active
- 2016-08-23 IL IL247442A patent/IL247442B/en active IP Right Grant
-
2019
- 2019-03-25 US US16/363,846 patent/US11124573B2/en active Active
-
2020
- 2020-05-14 JP JP2020084900A patent/JP7593745B2/ja active Active
- 2020-05-18 IL IL274735A patent/IL274735B/en unknown
-
2021
- 2021-04-27 AU AU2021202578A patent/AU2021202578B2/en active Active
- 2021-08-20 US US17/407,814 patent/US12071482B2/en active Active
-
2022
- 2022-04-14 JP JP2022066669A patent/JP7600172B2/ja active Active
-
2024
- 2024-06-25 US US18/753,820 patent/US20250011432A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7600172B2 (ja) | エンジニアリングされたＦｃ構築物に関連する組成物および方法 | |
| US12448423B2 (en) | Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains | |
| US12404339B2 (en) | Method of depleting target antigen-specific antibody from a patient by administering a fusion protein (Seldeg) for selectively depleting antigen-specific antibodies | |
| ES2973251T3 (es) | Composiciones y procedimientos relacionados con construcciones de Fc modificadas genéticamente | |
| US9458245B2 (en) | ANTI-C-MET tandem Fc bispecific antibodies | |
| AU2019235433B2 (en) | Bispecific EGFR/CD16 antigen-binding protein | |
| TWI804572B (zh) | 雙特異性抗體 | |
| US20140294834A1 (en) | Tandem fc bispecific antibodies | |
| JP2018512145A5 (enExample) | ||
| JP2016527314A5 (enExample) | ||
| SI2802606T1 (en) | Improves the transfer of healing molecules through the hematoencephalic barrier | |
| TW201803899A (zh) | 三特異性和／或三價結合蛋白 | |
| JP2015531751A (ja) | 選択的対である軽鎖および重鎖を含む免疫グロブリン構築物 | |
| US20260109748A1 (en) | Modulation of dendritic cell lineages | |
| JP2019519527A5 (enExample) | ||
| CN108473571A (zh) | 结合人Fc受体的融合蛋白 | |
| BR112019013955A2 (pt) | Composições e métodos relacionados a construtos de fc manipulados | |
| CA3164646A1 (en) | Antibodies conjugated with fatty acid molecules and uses thereof | |
| WO2022056197A1 (en) | Immune targeting molecules and uses thereof | |
| WO2021126538A1 (en) | Bispecific antibodies with alternatively matched interchain cycteines and uses thereof | |
| US20240124574A1 (en) | Bispecific Antibodies with Charge Pairs and Uses Thereof | |
| ES2960329T3 (es) | Proteínas de unión triespecíficas y/o trivalentes | |
| TW202102544A (zh) | 雙特異性抗體 | |
| JP2017524675A5 (enExample) | ||
| JP7684656B2 (ja) | 免疫抑制剤 |